Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Methane | HCID 297 | — |
| Reactant | Norchlorcyclizine | HCID 9340 | — |
| Reactant | Sodium Carbonate | HCID 10340 | — |
| Reactant | 2-(2-Chloroethoxy)acetamide | HCID 11018931 | — |
| Catalyst | Potassium Iodide | HCID 4875 | — |
| Solvent | Toluene | HCID 1140 | — |
| Product | Cetirizine amide | HCID 3068840 | 79.6% |
Reaction Steps
77 g (0.2685 mole) of levorotatory (-)-1-[(4-chlorophenyl)phenylmethyl]piperazine (prepared in Example 4.1), 40.5 g (0.2932 mole) of 2-(2-chloroethoxy)acetamide, 62.8 g (0.591 mole) of sodium carbonate and 2 g (0.0120 mole) of potassium iodide are added to 700 ml of toluene. The mixture is heated at reflux temperature for 24 hours. 10 g of Norit are then added and the mixture is filtered while hot through Dicalite. The filtrate is washed with 500 ml of water and then with 500 ml of a saturated aqueous solution of sodium chloride. The organic phase is separated and dried over 250 g of sodium sulfate. It is then filtered and the solvent is evaporated. The residual oil is taken up in 1500 ml of hot diisopropyl oxide. The solution is heated under reflux and allowed to crystallize by cooling in an ice bath. The crystals are filtered, washed with a small amount of diisopropyl oxide and dried under vacuum at 40° C. 82.91 g of levorotatory (-)-2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetamide are obtained.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05792770 |
|---|
| Source dataset | uspto-grants-1998_08 |
|---|
| ORD ID | ord-2a5e81e03d724d4a9aa9ae06e83a569d |
|---|
| Source note | uspto-grants-1998_08 |
|---|